Ecoflac infusion solutions: risk of air embolism
- Medicines and Healthcare products Regulatory Agency
- 1 November 2007
- Therapeutic area:
- Anaesthesia and intensive care, Cancer, Cardiovascular disease and lipidology, Dentistry, Dermatology Ear, nose and throat, Endocrinology, diabetology and metabolism, GI, hepatology and pancreatic disorders, Haematology, Immunology and vaccination, Immunosuppression and transplantation, Infectious disease, Neurology, Nutrition and dietetics, Obstetrics, gynaecology and fertility, Ophthalmology, Paediatrics and neonatology, Pain management and palliation, Psychiatry, Radiology and imaging, Respiratory disease and allergy, Rheumatology, and Urology and nephrology
To avoid the risk of air embolism, these products should not be infused under pressure.
Article date: November 2007
These semi-rigid plastic containers contain infusion solutions (glucose, KCl, or NaCl) for intravenous administration. They are designed to collapse during use, and they include a substantial volume of air. To avoid the risk of air embolism, these products should not be infused under pressure. It is recommended that they are used under gravity feed with a drip tube or an intravenous infusion pump to minimise the risk of air embolism. Partially used containers should not be reused.
Article citation: Drug Safety Update November 2007, vol 1 issue 4: 10c.
Published: 1 November 2007
Therapeutic area: Anaesthesia and intensive care Cancer Cardiovascular disease and lipidology Dentistry Dermatology Ear, nose and throat Endocrinology, diabetology and metabolism GI, hepatology and pancreatic disorders Haematology Immunology and vaccination Immunosuppression and transplantation Infectious disease Neurology Nutrition and dietetics Obstetrics, gynaecology and fertility Ophthalmology Paediatrics and neonatology Pain management and palliation Psychiatry Radiology and imaging Respiratory disease and allergy Rheumatology Urology and nephrology